⚖️ High Court tells FDA to chill, restores Cipla's license
The Maharashtra FDA withdrew its cancellation of Cipla Pharma & Life Sciences’ Pune drug sale warehouse licence after the Bombay High Court stepped in. The High Court pulled up the regulator for being "high-handed" and violating natural justice principles on August 26. The FDA had previously cancelled the licence over alleged irregularities with Reactin Plus Tablets, effective from August 27. Cipla argued the cancellation blocked critical life-saving medicines from reaching patients due to the hasty process. The High Court questioned the FDA's transparency in handling the adjournment request during a public holiday.